The highly sensitive C-reactive protein (hs-CRP) test is an early detection method for people at risk for cardiovascular disease. In particular, the severity of acute myocardial infarction is strongly correlated with hsCRP levels.

Screening and primary prevention of cardiovascular events are essential, especially in high-risk subjects. Along with common tests and tools, C-reactive protein (CRP) is increasingly showing its role in the prevention of atherosclerosis.

Inflammation is the body's response to injury. The CRP test measures the amount of C-reactive protein in the blood. The CRP test is primarily used to assess the level of inflammation and monitor the response to treatment of infectious diseases.

CRP testing helps assess the body's infection status and monitor the response of inflammation to treatment. In addition, the CRP index also helps screen for coronary heart disease (CHD), cardiovascular disease in people who appear healthy.

C-reactive protein testing is indicated in cases where inflammation is present. However, not many people know what C-reactive protein is and how valuable it is in diagnosing the disease.

To investigate the risk of cardiovascular diseases which are increasingly common today, the high-sensitivity C-reactive protein test is a valuable paraclinical test to assess the risk of inflammation in cardiovascular diseases, thereby providing the most appropriate treatment method.

Rheumatoid arthritis is a very common disease today, can be found in all ages. It causes damage to joints and cartilage, causing many disadvantages in daily life.

Inflammation is the body's response to and protection against injury. Quantitative CRP blood test, which characterizes the level and condition of inflammation in the patient, helps doctors monitor, evaluate and provide appropriate treatment for the patient.